SEC Tracker
Get the app

Rallybio RLYB

Rallybio Corporation and Candid Therapeutics Announce Merger Agreement

Form
8-K
Filed
Importance
Notable
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Rallybio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025
  2. Kiora Pharmaceuticals KPRX public float $10M, Jun 30, 2025
  3. Scienture Holdings SCNX public float $10M, Jun 30, 2025
  4. Phio Pharmaceuticals PHIO public float $11M, Jun 30, 2025
  5. Palisade Bio PALI public float $11M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.